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Indirect immunofluorescence was performed on skin 
from 13 patients with epidermolysis bullosa (EB) (sim-
plex, 6; junctional, 2; dystrophic, 5) to compare the 
expression of 3 basement membrane components, bul-
lous pemphigoid (BP) antigen, cicatricial pemphigoid 
(CP) antigen, and epidermolysis bullosa acquisita (EBA) 
antigen, in clinically uninvolved tissue. In addition, 
expression of laminin, type IV collagen, and KF-1 anti-
gen was also evaluated. Whereas laminin, type IV col-
lagen, and KF -1 antigen were each detectable in EB 
skin in a manner identical to that previously reported, 
marked variability was noted in the expression of BP, 
CP and EBA antigens. However, no correlation was 
not~d comparing lack of expression of any one of these 
latter antigens with either of the remaining two. Of 
these 3 antigens, BP antigen was the least often detect-
able, particularly in skin from ~atie~ts with EB simplex. 
The lack of detectable BP antigen m EB simplex skin 
appeared to correlate with more extensive disease in-
volvement and/or younger patient age. These findings 
may, therefore, limit the. usefuln~s~ of BP serum in 
immunofluorescence mapping. Additionally, the dispar-
ity in expression of basement membrane antigens de-
fined by BP and CP sera suggests that BP antigen and 
CP antigen are distinct entities. 
Previous studies have demonstrated that antibodies to three 
known components of human skin basement membrane zone 
(BMZ), bullous pemphigoid ~BP) antigen, laminin, and type IV 
collagen, may prove useful m assessment of the level of skin 
cleavage and therefore in the classification of patients with 
epidermolysis bullosa (EB); each of these 3 basement mem-
brane antigens is reportedly detectable in seemingly normal 
amounts in intact and freshly blistered EB skin [1,2) . More 
recently, using the KF-1 monoclona~ antibody [3), which is 
directed against a noncollagenous !aroma densa antigen within 
primate stratified squamous epithelial dermoepidermal junc-
tion, a new antigenic defect rec~ntly has been defined in both 
dominant and recessive forms of dystrophic EB [4). 
In these previously published studies, the expression of BP 
antigen, laminin, and type IV collagen has been normal in skin 
from patients with each of the 3 types of EB. 
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There are 2 additional autoimmune bullous diseases of the 
skin in which circulating autoantibodies reacting against BMZ 
components occur. One of these, cicatricial pemphigoid (CP), 
is indistinguishable from BP by routine histologic and immu-
nofluorescence (IF) parameters although clinically such pa-
tients are usually quite distinctive. Recent studies using im-
munoelectron microscopy (IEM) have confirmed that in vivo-
bound immunoreactants in this disease occur within the lamina 
Iucida, the same portion of the dermoepidermal junction in 
which immunoreaction products are deposited in both BP and 
herpes gestationis [5). In contrast to BP, however, the occur-
rence of circulating antibasement membrane zone antibodies 
in CP is a very infrequent finding [6,7]. Using mechanically 
induced suction blisters on clinically normal skin of 2 patients 
containing in vivo-bound immunoreactants in CP, we have 
recently shown that these immunoreactants appear to be pres-
ent only on the base of the lamina lucida-induced blister in 
contrast to BP antigen which is localized to the blister roof 
[5], suggesting the possibility that different lamina Iucida an-
tigens may be involved in the pathogenesis of lesions in BP 
and CP. 
A second disease with in vivo-bound immunoreactants and 
circulating autoantibodies to BMZ is epidermolysis bullosa 
acquisita (EBA) [8,9). In this disease, in vivo-bound materials 
are detectable beneath the lamina densa within the upper 
portion of the papillary dermis. In addition , circulating auto-
antibodies, although infrequently seen, bind within and just 
beneath the lamina densa of normal human skin. 
The purpose of this study was to determine whether the BMZ 
antigens detectable with autoantibodies from patients with CP 
and EBA are also expressed normally in clinically uninvolved 
skin from patients with EB and if not, whether such defective 
antigenic expression can be correlated with the ultrastructural 
sites of skin cleavage and injury in such patients. 
MATERIALS AND METHODS 
Source of Autoantibodies 
Sera were obtained from 2 patients meeting clinical and immuno-
pathological criteria for CP. Both patients had marked desquamative 
gingivitis, gingival erosions and vesicles, conjunctival involvement and 
only occasional extramucosal blisters. Direct IF studies of buccal mu-
cosa and perilesional skin in both patients revealed linear deposition 
of multiple immunoreactants along the epithelial-dermal junction. Sera 
from both patients were positive for antibasement membrane zone 
autoantibodies as detectable by indirect IF on normal human skin. 
Autoantibodies from patient CP-1 were initially detectable at a titer of 
1:64 but on subsequent sampling were detectable at a titer of only 1:8; 
antibasement membrane antibodies were present at a titer of only 1:4 
in patient CP-2. IF mapping and IEM confirmed the localization of 
cleavage plane formation and in vivo-bound immunoreactants within 
the lamina Iucida in lesional and perilesional tissue, respectively. 
Serum was obtained from 1 patient meeting clinical criteria for EBA; 
findings included marked skin fragility, tense blisters, erosions, milia, 
scarring, normal or abnormal nails, early digital webbing, and mucous 
membrane involvement (oral, esophageal). Direct IF revealed intense 
and somewhat broad deposition of immunoreactants along the dermo-
epidermaljunction. IEM revealed immunoreactants beneath the lamina 
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densa. Indirect IF with this patient's serum (EBA-1) revealed anti-
basement membrane antibodies through a t iter of 1:64. 
Sera from 4 patients known to have BP were utilized in this study. 
Each of these patients had typical features of BP, had in vivo-bound 
immu noreactants a long the dermoepidermal junction on direct IF of 
skin , had circulating antibasement membrane antibodies, and by IEM 
had immunoreactants detectable within t he lamina Iucida. Serum from 
patient BP-1 had ant.ibasement membrane a ntibodies detectable 
through a titer of 1:80. Sera from patients BP-2, -3, and -4 were the 
generous gifts of Ray Gammon, M.D. (Chapel Hill , North Carolina) ; 
each of these latte r 3 sera were positive by indirect IF t hrough a titer 
of 1:640. 
Other Reagents 
Fluoresceinated goat antihuman lgG was obtained from Cappel 
Laboratories (Cochranvi lle, Pennsylva nia) and was used at 1:40 dilu-
t ion. 
Shin Specimens Examined 
Four millimeter punch biopsies were obtained from clinically nor-
mal-appearing skin from t he flexura l aspects of the upper arms of 6 
patients with EB simplex (Weber-Cockayne, 4; generalized, 2), 2 pa-
tients with junctional EB (Herlitz variety), and 5 patients with dys-
trophic EB (dom inant, l ; recessive, 4). Diagnosis was established in 
each patient on the basis of clinical findin gs, family history, IF mapping 
a nd KF-l monoclonal antibody studies, and additionally in some pa-
tients, by electron microscopy. 
Sim ilar s kin specimens were obtained from normal adult volunteers, 
surgical amputations, and cadavers, and served as control tissue. 
Each skin specimen was embedded in OCT compound (Lab-Tek 
Products, Napervi lle, Ill inois), snap frozen, and stored at -7o·c until 
ready for section ing. 
Indirect lmmuofluorescence Studies 
Six-11m cryostat sections of unfixed specimens of skin from EB 
patients and normal adu lt volunteers were placed on albuminized sl ides 
a nd stained by routine indirect IF technique using antisera at the 
foll owing dilutions: CP-l , 1:2; CP -2, undiluted; BP-1 , -2, -3, and -4, 
each at 1:10; EBA -1, 1:5; a nd normal human serum at 1:2, 1:5, and 
1:10. All dilutions were prepared in 0.0067 M phosphate-buffered saline 
(PBS) at pH 7.4 . Following 30 min incubation of the ti ssues with each 
of these sera at room temperature within a humidified chamber, the 
slides were briefly washed in PBS, excess moisture removed, and 
subsequently re- incubated with fluoresceinated goat antihuman lgG 
(1:40 dilution) . Following an additional 30 min incubat ion a nd subse-
quent washing, eac h slide was mounted with 1:1 glycerol in PBS a nd 
examined by flu orescence microscopy. 
IF mapping studies using a nt ilaminin and antitype IV collagen as 
well as KF -1 monoclonal a ntibody studies were a lso performed on each 
tissue as prev iously described [1 ,4]. 
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RESULTS 
IF findings are listed in Table I. As is readily apparent from 
such data, there appears to be marked variability of expressioh 
of CP, BP, and to a much lesser extent, EBA antigens ih 
clinically uninvolved skin from patients with EB. In contrast, 
each of t hese antigens was expressed normally in control humah 
skin, as were laminin and type IV collagen. KF -1 antigen was 
expressed normally in skin from patients with simplex and 
junctional EB, expressed weakly in the one patient having 
dominant dystrophic EB, and was undetectable in sk in from 
each patient with recessive dystrophic EB, the latter findings 
in agreement with previously published data [4]. 
CP sera bound to the dermoepidermal junction of skin from 
3 of 6 patients with EB simplex, 1 of 2 patients with junctional 
EB, and 4 of 4 patients with recessive dystrophic EB. In the 
one specimen from a patient with dominant dystrophic EB, no 
binding was detectable with either CP serum. In 2 of the 4 
patients_with recessive dystrophic EB, only 1 of the 2 CP sera 
bound to tissue. In several of these specimens, CP sera bound 
only focally to the dermoepidermal junction. No correlatioh 
was noted between lack of binding by CP sera and extent of 
disease activity in EB simplex; no binding was seen in 2 of 4 
patients with Weber-Cockayne disease and 1 of 2 patients with 
generalized EB simplex. 
At least one of the 4 BP sera bound to the skin of 4 of 6 
patients with EB simplex, both patients with junctional EB, 
and all 5 patients with dystrophic EB. Although some of the 
BP se ra bound only focall y, each of the 4 bound to skin from 4 
of 4 patients with recessive dystrophic EB and 1 of 2 patients 
with junctional EB. In contrast, no basement membrane stain.-
ing was seen with any of the 4 BP sera in 2 of 6 patients with 
EB simplex. Staining with at least 2 of the 4 BP sera was seeh 
in the skin of only 3 of 6 patients with EB simplex. Furthet-
more, in those EB simplex specimens binding BP sera, 3 of 8 
positive EB simplex tissue sections had only focal positive 
staining. In a similar manner, only focal staining by BP sera 
was seen in 3 of 7 positive tissue sections from patients with 
junctional EB and 3 of 18 positive tissue sections from patients 
with dystrophic EB. It should be noted that these results were 
obtained using 1:10 dilutions of each of the BP sera; in contrast 
uniform positive linear basement membrane staining was see~ 
in each of the control human skin specimens using dilutions of 
1:40 and 1:640 of BP-1 and BP-2, -3 , and -4 sera, respectively_ 
Finally, it should be noted that the lack of expression of B:P 
TABLE I. Expression of six basement membrane antigens in epidermolysis bullosa (EB) skin 
Cicatricial 
pemphigoid Bullous pemphigo
id Antisera 
Type of EB Epidermolysis Type KF-1 
2 2 bullosa Laminin IV antigen 
acquisita-1 collagen 
Simplex 
Weber-Cockayne 
1 + (+) (+) (+) + + + + 
2 (+) + + (+) + + + + 
3 + + + + + + + 
4 + + + 
Gene ralized 
5 + + + + + + + 
6 + + + 
Junctiona l 
7 + + + + + + + + 
8 + (+) (+) (+) (+) + + + + 
Dystrophic 
Recessive 
9 + + + + + + + + + 
10 + + + + + + + + 
11 + + + + + + + + 
12 (+) (+) + + (+) (+) + + 
Dominant 
13 (+) + + + + (+) 
Key: + = uniformly present,(+)= focally present, and- = absent. 
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antigen in EB simplex skin appears most pronounced in either 
younger aged patients or in patients having the generalized 
form of the disease. 
Using EBA se rum, uniform binding was noted along the 
dermoepidermal junctio n in 10 of 13 EB patients. No correla-
tion was seen between lack of binding of EBA serum and type 
of EB or extent of disease activity. 
Closer examination of the data in Table I reveals t hat not 
only is there marked variability of expression of individual BP 
antigens (i.e. , not all an t isera bound to the same EB specimens) 
but also t hat there is disparity between the expression of CP 
and BP antigens. There also appears to be a lack of correlation 
between t he expression of bullous or c icatricial pemphigoid 
antigens and the EBA a ntigen . 
DISCUSSION 
Recent studies have demonstrated that the technique of IF 
mapping, using antibodies to B~ antige~ , laminin, and type IV 
collagen, is a reliable rneans of determmmg ultrastructurally 
where sk in cleavage develops in patients with EB [1,2]. In 
previously published studies, all 3 of these an t igens appeared 
to be uniformly expressed in a reproducible manner regardless 
of the type of EB skin examined. 
In the present study, skin specimens from clinically-unin-
volved sites of 13 patients with EB were examined by indirect 
IF for the expression of 6 basement membrane components. In 
all 13 of these patients, the expression of la minin, type IV 
collagen , and KF-1 was consistent with that previously re-
ported. In contrast, however, the expression of BP antigen, as 
defined by detection of basement membrane binding by one or 
more BP sera, was found to be a ltered primarily but not 
exclusively in skin from patients with EB simplex. 
There appears to be some correlati.on between the expression 
of BP antigen and the extent of d1sease activity in patients 
with EB simplex; as depicted in Table I, only 1 of 8 slides was 
positive in the 2 patients with generalized EB simplex whereas 
7 of 16 were positive in patients with the Weber-Cockayne 
variety of this disease. Another pos~ible correlation exists be-
tween the relative lack of expressiOn of BP antigen in EB 
simplex patients and patien t age. Both patients lacking any 
expression of BP antigen were less ~han 8 years of age; one 
additional patient (EB Simplex- patient 5) who had positive 
binding by only 1 of 4 BP sera was 14 years of age. The 
remaining three patients, all of whom have Weber-Cockayne 
disease, were older than age 60. 
These findings suggest that BP serum may be the least 
reliable of the immunoreagents used in IF mapping, particularly 
when EB simplex skin i~ to be examined. Despite this, however, 
one can still reliably utilize antibodies to laminin and type IV 
collagen in order to atternpt to localize cleavage plane formation 
in EB skin. 
The second point to be emphasized is that there also appears 
to be marked variability of expression of the CP antigen(s) in 
skin from patients with the various forms of EB, especially the 
simplex form. In contr::JSt to BP antigen, however, no correla-
tion was noted betweeo the extent of disease activity and/or 
patient age in EB simplex and the lack of reactivity with CP 
sera. 
It should be further e mphasized that there appears in some 
cases to be marked disparity between binding by CP and BP 
se ra within skin from the same patient. These findings would 
confirm our previous experience with localization of CP in vivo-
bound immunoreactants following mechanical suction blister 
induction [5]. That is, these data would suggest that BP and 
CP autoantibodies bind to antigenically distinct basement 
membrane components, a plausible conclusion since these 2 
diseases appear to have marked differences in tissue sites of 
involvement as well as (elative tendency for scar formation. 
In addition, the finding that only 1 of 2 CP sera bound to 
skin from 2 of the patients with recess ive dystrophic EB sug-
gests that there may be at least 2 different antigens recognized 
by CP autoantibodies. This would not be surprising since there 
is now evidence from several laboratories that t here are prob-
ably several different BP [10-15] and pemphigus vulgaris [16-
19] antigens, as suggested by variations in antigen expression 
within tissue and by differences in molecular weights of ex-
tracted antigens. 
In contrast to cicatricial and bullous pemphigoid antigens, 
the EBA antigen appears to be relatively well-expressed in EB 
skin. Furthermore, its presence in recessive dystrophic EB skin 
confirms its lack of identity with the KF-1 antigen. 
It is as yet unknown what role, if any, these BMZ antigenic 
defects serve in enhancing skin fragility and facilitating blister 
formation in patients with simplex, junctional, and dystrophic 
forms of EB. Further work directed at more complete charac-
terization of these antigens will hopefully better clarify this 
latter issue. 
The author wishes to acknowledge the excellent technical assistance 
of Mrs. Barbara Stewart. In addition, the author gratefully acknowl-
edges advice and support by Dr. W. Mitchell Sams, Jr. , during the 
course of this and related studies. 
REFERENCES 
1. Hintner H, Sting! G, Schuler G, Fritsch P, Stanley J, Katz S, Wolff 
K: Immunofluorescence mapping of antigenic determinants 
within the dermal-epidermal junction in mechanobullous dJs-
eases. J Invest Dermatol 68:119-124, 1981 
2. Weber L, Krieg T , Muller PK, Kirsch E, Timpl R: Immunoflu-
orescent localization of type IV collagen and Jammm m humlln 
skin and its application in junctional zone pathology. Br J 
Dermatol 106:267- 273, 1982 
3. Breathnach, SM, Fox PA, Neises GR, Stanley JR, Katz SI: A 
unique squamous epithelial basement membrane antigen defined 
by a monoclonal antibody (KF-1). J Invest Dermatol 80:392-
395, 1983 
4. Fine JD Breathnach SM Hintner H Katz SI: KF-1 monoclonal antib~dy defines a spe~ific baseme~t membrane antigen defect 
in dystrophic forms of epidermolysis bullosa. J Invest Dermatol 
82:35-38, 1984 . 
5. Fine JD Neises GR Katz SI: Immunofluorescence and Immunoe-Jectro~ microscopic studies in cicatricial pemphigoid. J Invest 
Dermatol 82:39-43, 1984 . 
6. Nisengard RJ, Jablonska S, Beutner EH, Shu S~ ~horzelski TP, 
Jarzabek M, Blaszczyk M, Rzesa G: DiagnostiC Importance of 
immunofluorescence in oral bullous diseases and lupus erythe-
matosus. Oral Surg 40:365-375, 1975 . . . 
7. Laskaris G, Angelopoulos A: Cicatricial pemphigOid: direct and 
indirect immunofluorescent studies. Oral Surg 51:48-54, 1981 
8. Yaoita H, Briggaman RA, Lawley TJ, Provost TT,. Katz SI: Epi-
dermolysis bullosa acquisita: ultrastructural and Immunological 
studies. J Invest Dermatol 76:288-292, 1981 
9. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO , Queen LL, 
Gammon WR: Identification of the skin basement-membrane 
autoantigen in epidermolysis bullosa acquisita. J Invest Derma-
to! 310:1007- 1013, 1984 
10. Diaz L, Calvanico N, Tomasi T, Jordon R: Bullous pemphig,, id 
antigen: isolation from normal human skin. J Immunol 118:4J5-
460, 1977 
11. Diaz L, Patel H, Calvanico N: Bullous pemphigoid antigen: isola-
tion from the urine of a patient. J Immunol 122:605- 608, 1979 
12. Lohrisch I, Herrmann K, Haustein U-F: Detection of basement 
membrane zone antigens and C3 fragments in the blister fluid 
of bullous pemphigoid. Br J Dermatol102:135- 143, 1980 
13. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI: 
Characterization of bullous pemphigoid antigen: a unique base-
ment membrane protein of stratified squamous epithelia. Cell 
24:897- 903, 1981 
14. Stanley JR, Woodley DT, Katz SI: Identification of pemphigoid 
antigen extracted from normal human skin. J Invest Dermatol 
82:108-111, 1984 
15. Zhu X-J, Bystryn J-C: The heterogeneity of pemphigoid antigens. 
J Invest Dermatol 80:16-20, 1983 
16. Shu SY, Beutner EH: Isolation and characterization of antigens 
reactive w1th pemphigus antibodies. J Invest Dermatol 61:270-
276, 1973 
17. Diaz LA, Patel H, Calvanico NJ: Isolation of pemphigus antigen 
from hum~n saliva. J Immunol124:760-765, 1980 
18. Stanley JR, Yaar M, Hawley-Nelson P, Katz SI: Pemphigus anti-
bodies Identify a cell surface glycoprotein synthesized by human 
and mouse keratinocytes. J Clin Invest 70:281- 288, 1982 
19. Peterson LL, Wuepper KD: Isolation and purification of a pem-
phigus vulgans antigen from human epidermis. J Clin Invest 
73:1113- 1120, 1984 
